To,
Management Team
Regenix
Subject: Proposal for third-party manufacturing & Strategic Support for Dedicated Insulin Division
Dear Sir/Madam,
We would like to introduce TCSOL Biopharma as a professionally managed pharmaceutical company engaged in third-party manufacturing, marketing, and institutional supply of pharmaceutical and healthcare products across India.
TCSOL Biopharma has established a strong presence in Government and Defence healthcare sectors, including Army, Navy, and Air Force Hospitals nationwide. The company operates under valid pharmaceutical licences and certifications, including:
UDYAM Registration
UDYAM-TN-02-0153340
Drug Licences
HR/WLF20B2023HR0345
HR/WLF21B2024HR0343
Manufacturing Loan Licences
L/22/2864/MNB
L/22/2865/MB
Certifications
GMP & GLP Certified
As part of our future expansion strategy, we are planning to launch a dedicated Diabetic & Insulin Care Division, which will exclusively focus on insulin products and diabetic healthcare solutions.
- third-party manufacturing insulin products
- Product development support
- Regulatory and technical guidance
- Supply and production collaboration
- third-party manufacturing under our own brand name
We believe that with the third-party manufacturing expertise of Regenix and the institutional market presence of TCSOL Biopharma, this collaboration can create a strong and successful business partnership in the diabetic healthcare segment.
We look forward to your positive response and the opportunity to discuss this proposal further.